MediPharm Labs Corp.

OTCPK:MEDI.F Stock Report

Market Cap: US$18.5m

MediPharm Labs Management

Management criteria checks 3/4

MediPharm Labs' CEO is David Pidduck, appointed in Apr 2022, has a tenure of 2.75 years. total yearly compensation is CA$1.31M, comprised of 36% salary and 64% bonuses, including company stock and options. directly owns 4.47% of the company’s shares, worth $826.89K. The average tenure of the management team and the board of directors is 5.3 years and 5.6 years respectively.

Key information

David Pidduck

Chief executive officer

CA$1.3m

Total compensation

CEO salary percentage36.0%
CEO tenure2.8yrs
CEO ownership4.5%
Management average tenure5.3yrs
Board average tenure5.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has David Pidduck's remuneration changed compared to MediPharm Labs's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-CA$12m

Jun 30 2024n/an/a

-CA$13m

Mar 31 2024n/an/a

-CA$14m

Dec 31 2023CA$1mCA$470k

-CA$13m

Sep 30 2023n/an/a

-CA$16m

Jun 30 2023n/an/a

-CA$20m

Mar 31 2023n/an/a

-CA$26m

Dec 31 2022CA$3mCA$315k

-CA$30m

Compensation vs Market: David's total compensation ($USD903.36K) is above average for companies of similar size in the US market ($USD645.47K).

Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.

CEO

David Pidduck

2.8yrs

Tenure

CA$1,305,051

Compensation

Mr. David A. Pidduck is Chief Executive Officer and Director at MediPharm Labs Corp. since April 20, 2022. Mr. Pidduck has been the Chief Executive Officer and President of Purdue Pharma Inc. since Septemb...

Leadership Team

NamePositionTenureCompensationOwnership
David Pidduck
CEO & Director2.8yrsCA$1.31m4.47%
$ 826.9k
Keith Strachan
Co-Founder & President5.9yrsCA$819.48k2.28%
$ 421.5k
Greg Hunter
Chief Financial Officer3.9yrsCA$957.75k0.42%
$ 78.0k
Patrick McCutcheon
Founder10yrsCA$858.16kno data
Brett Moon
Vice President of Sales4.7yrsno datano data
Kirk Binns
Executive Vice President of Global Accounts5.9yrsno datano data

5.3yrs

Average Tenure

Experienced Management: MEDI.F's management team is seasoned and experienced (5.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
David Pidduck
CEO & Director2.8yrsCA$1.31m4.47%
$ 826.9k
Shelley Martin
Independent Director4.6yrsCA$64.49k0.039%
$ 7.2k
Michael Bumby
Independent Director1.8yrsCA$34.45k0.072%
$ 13.3k
Christopher Taves
Independent Chairman of the Board4.5yrsCA$87.14k0.45%
$ 83.1k
Miriam McDonald
Member of the Science Advisory Board5.8yrsCA$32.40kno data
Leslie Brown
Member of the Science Advisory Board5.8yrsno datano data
Matt Archibald
Member of the Science Advisory Board5.8yrsno datano data
Markus Roggen
Member of the Science Advisory Board5.8yrsno datano data
Arshad Hack
Member of the Science Advisory Board5.8yrsno datano data
Jerry King
Member of the Science Advisory Board5.8yrsno datano data
Carolina Landolt-Marticorena
Member of the Science Advisory Board5.4yrsno datano data
Christopher Halyk
Independent Director4.4yrsCA$56.05k0.064%
$ 11.9k

5.6yrs

Average Tenure

Experienced Board: MEDI.F's board of directors are considered experienced (5.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/05 16:00
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MediPharm Labs Corp. is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Aaron GreyAlliance Global Partners
Tamy ChenBMO Capital Markets Equity Research
Kimberly Thompson-HedlinCanaccord Genuity